Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,985
41 years, by papers

Newest first

3,801 to 3,850 of 3,985

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • Ondansetron and metformin-induced gastrointestinal side effects.

    American journal of therapeutics2003PMID 14624284

  • Effect of metformin on fibrinolytic parameters in insulin-treated, type 2 diabetic patients.

    Diabetes & metabolism2003PMID 14631327

  • The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients.

    Diabetes care2003PMID 14633813

  • Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.

    Archives of internal medicine2003PMID 14638559

  • Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.

    Antiviral therapy2003PMID 14640387

  • The combination metformin/glyburide exerts its hypoglycemic effect mainly by increasing insulin secretion: a controlled, randomized, double-blind, crossover study.

    Diabetes, nutrition & metabolism2003PMID 15000437

  • Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects.

    Diabetes2002PMID 11756319

  • Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial.

    Diabetes care2002PMID 11772907

  • Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome.

    Fertility and sterility2002PMID 11779598

  • Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects.

    Diabetes2002PMID 11812753

  • Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial.

    Human reproduction (Oxford, England)2002PMID 11821265

  • Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

    The New England journal of medicine2002PMID 11832527

  • Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial.

    The Journal of clinical endocrinology and metabolism2002PMID 11836287

  • Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization.

    Endocrinology2002PMID 11861525

  • Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients.

    Diabetic medicine2002PMID 11874430

  • Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity.

    Diabetes, obesity & metabolism2002PMID 11874442

  • Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.

    Diabetes care2002PMID 11874944

  • Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid.

    Endocrine practice2002PMID 11951812Indexed under metformin in PubMed's chemical list

  • Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice.

    British journal of clinical pharmacology2002PMID 11994052

  • The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

    The Journal of biological chemistry2002PMID 11994296

  • Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes.

    Diabetes/metabolism research and reviews2002PMID 11994904

  • Nateglinide improves glycaemic control when added to metformin monotherapy: results of a randomized trial with type 2 diabetes patients.

    Diabetes, obesity & metabolism2002PMID 12047396

  • Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.

    Diabetes, obesity & metabolism2002PMID 12047399

  • The contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin.

    Diabetes research and clinical practice2002PMID 12062853

  • Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

    The Cochrane database of systematic reviews2002PMID 12076461

  • Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.

    Diabetes care2002PMID 12087008

  • Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study.

    Human reproduction (Oxford, England)2002PMID 12093831

  • Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.

    Diabetic medicine2002PMID 12147149

  • The effect of metformin on hirsutism in polycystic ovary syndrome.

    European journal of endocrinology2002PMID 12153743

  • Effect of cephalexin on the pharmacokinetics of metformin in healthy human volunteers.

    Drug metabolism and drug interactions2002PMID 12222753

  • Repaglinide versus metformin in combination with bedtime NPH insulin in patients with type 2 diabetes established on insulin/metformin combination therapy.

    Diabetes care2002PMID 12351462

  • Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes.

    Diabetes care2002PMID 12351463

  • A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.

    Diabetes care2002PMID 12351470

  • Bioequivalence evaluation of two brands of metformin 500 mg tablets (Dialon & Glucophage)--in healthy human volunteers.

    Biopharmaceutics & drug disposition2002PMID 12355581

  • Circulating ghrelin levels in patients with polycystic ovary syndrome.

    The Journal of clinical endocrinology and metabolism2002PMID 12364442

  • Sustained benefits of metformin therapy on markers of cardiovascular risk in human immunodeficiency virus-infected patients with fat redistribution and insulin resistance.

    The Journal of clinical endocrinology and metabolism2002PMID 12364443

  • Discontinuation of metformin in type 2 diabetes patients treated with insulin.

    The Netherlands journal of medicine2002PMID 12365468

  • Effects of berberine on glucose metabolism in vitro.

    Metabolism: clinical and experimental2002PMID 12404195Indexed under metformin in PubMed's chemical list

  • Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy.

    Diabetes, obesity & metabolism2002PMID 12406033

  • Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect.

    The American journal of cardiology2002PMID 12423711

  • Pharmacokinetics and pharmacodynamics of glyburide/metformin tablets (Glucovance) versus equivalent doses of glyburide and metformin in patients with type 2 diabetes.

    Clinical pharmacokinetics2002PMID 12452739Returned by a PubMed search for metformin

  • Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.

    Diabetes2002PMID 12453903

  • Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects.

    Diabetes care2002PMID 12453948

  • Combination of insulin and metformin in the treatment of type 2 diabetes.

    Diabetes care2002PMID 12453950

  • The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients.

    Diabetes care2002PMID 12453953

  • Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone.

    Fertility and sterility2001PMID 11172832

  • Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome.

    The Journal of clinical endocrinology and metabolism2001PMID 11238496

  • Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics.

    Diabetes research and clinical practice2001PMID 11269893Indexed under metformin in PubMed's chemical list

  • Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects.

    Diabetes care2001PMID 11289473

  • Improved endothelial function with metformin in type 2 diabetes mellitus.

    Journal of the American College of Cardiology2001PMID 11300445

The next 50 papers

← Previous 50